Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: A case-control study from China

Pancreas

Volumn 41, Issue 3, 2012, Pages 435-440

  Ben, Qiwen ^a,b   Li, Zhaoshen ^a,b   Liu, Chunxing ^c   Cai, Quancai ^a,b   Yuan, Yaozong ^d   Wang, Kaixuan ^a   Xiao, Lining ^a   Gao, Jun ^b   Zhang, Huagao ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Shanghai Jiaotong University ^*  (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

case control study; hepatitis B virus; pancreatic ductal adenocarcinoma; risk factors

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER RISK; CHRONIC HEPATITIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREATIC DUCTAL ADENOCARCINOMA; PRIORITY JOURNAL; SEX;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; DIABETES MELLITUS; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 84859066778     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31822ca176     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.
2. Le Scodan R, Mornex F, Girard N, et al. Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review. Ann Oncol. 2009;20:1387-1396.
3. Verslype C, Van Cutsem E, Dicato M, et al. The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol. 2007;18(suppl 7):vii1-vii10.
4. Lavanchy D. Hepatitis Bvirus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97-107. (Pubitemid 38365759)
5. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006;43:S173-S181.
6. Yoshimura M, Sakurai I, Shimoda T, et al. Detection of hBsAg in the pancreas. Acta Pathol Jpn. 1981;31:711-717.
7. Dejean A, Lugassy C, Zafrani S, et al. Detection of hepatitis Bvirus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol. 1984;65(Pt 3):651-655. (Pubitemid 14159007)
8. Talamini R, Montella M, Crovatto M, et al. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer. 2004;110:380-385. (Pubitemid 38649889)
9. El-Serag HB, Engels EA, Landgren O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology. 2009;49:116-123.
10. Iloeje UH, Yang HI, Jen CL, et al. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Liver Int. 2010;30:423-429.
11. Berrington de Gonzalez A, Yun JE, Lee SY, et al. Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study. Cancer Epidemiol Biomarkers Prev. 2008;17:359-364.
12. Hassan MM, Li D, El-Deeb AS, et al. Association between hepatitis Bvirus and pancreatic cancer. J Clin Oncol. 2008;26:4557-4562.
13. Ben Q, Cai Q, Li Z, et al. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer. 2011;47:248-254.
14. Ben Q, Wang K, Yuan Y, et al. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer. 2011;128:1179-1186.
15. Suzuki T, Matsuo K, Hasegawa Y, et al. Anthropometric factors atage 20 years and risk of thyroid cancer. Cancer Causes Control. 2008;19:1233-1242.
16. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507-539. (Pubitemid 46374607)
17. Pawlotsky JM, Lonjon I, Hezode C, et al. What strategy should beused for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology. 1998;27:1700-1702. (Pubitemid 28264697)
18. Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol. 1976;103:506-511.
19. Zhang QH, Guo XQ, Chun YL, et al. Study onHBV serological markers of inhabitants from Shanghai Songjiang district (in Chinese). Chin J Public Health. 2008;24:1389-1390.
20. Munoz SJ. Use of hepatitis Bcore antibody-positive donors for liver transplantation. Liver Transpl. 2002;8:S82-S87. (Pubitemid 35154048)
21. Shimoda T, Shikata T, Karasawa T, et al. Light microscopic localization of hepatitis B virus antigens in the human pancreas. Possibility of multiplication of hepatitis B virus in the human pancreas. Gastroenterology. 1981;81:998-1005.
22. Paterlini-Brechot P, Saigo K, Murakami Y, et al. Hepatitis Bvirus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene. 2003;22:3911-3916. (Pubitemid 36819664)
23. Brechot C, Pourcel C, Louise A, et al. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature. 1980;286:533-535. (Pubitemid 10017698)
24. Brechot C. Pathogenesis of hepatitis Bvirus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology. 2004;127:S56-S61. (Pubitemid 39423370)
25. Hassan MM, Hwang LY, Hatten CJ, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002;36:1206-1213. (Pubitemid 35253437)
26. Chen CL, Yang HI, Yang WS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology. 2008;135:111-121.
27. Suzuki H, Li Y, Dong X, et al. Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:3467-3473.
28. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care. 1999;22:1978-1983. (Pubitemid 30433975)
29. Ksiazek K, Mikula-Pietrasik J, Catar R, et al. Oxidative stress-dependent increase in ICAM-1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium. Int J Cancer. 2010;127:293-303.
30. Wheatley-Price P, Asomaning K, Reid A, et al. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer. 2008;112:1037-1042. (Pubitemid 351304587)